Fermenta Biotech Ltd

₹ 207 3.21%
30 Sep - close price
About

FBL, incorporated in 1986, has two business segments; i.e. manufacturing of active pharmaceutical ingredients (APIs) and lease rental business for commercial properties developed in Thane.

Key Points

Key Product Segments
The company’s business can be classified majorly under five segments which are Vitamin D3, specialty APIs, biological enzymes and biotech based environmental solutions and rental business. FBL manufactures a range of Vitamin D3 variants having an optimal mix between human and animal feed products. [1]

  • Market Cap 610 Cr.
  • Current Price 207
  • High / Low 334 / 176
  • Stock P/E 415
  • Book Value 126
  • Dividend Yield 0.60 %
  • ROCE 7.47 %
  • ROE 4.11 %
  • Face Value 5.00

Pros

  • Company has been maintaining a healthy dividend payout of 21.1%

Cons

  • Company has low interest coverage ratio.
  • Company has a low return on equity of 11.8% over last 3 years.
  • Company might be capitalizing the interest cost
  • Promoter holding has decreased over last 3 years: -3.01%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022
81.18 80.78 66.45 64.54 94.44 93.37 89.99 99.49 109.65 99.85 92.86 96.16 91.89
56.67 65.17 52.66 55.11 72.08 66.44 67.79 89.31 83.87 84.14 90.65 78.40 86.95
Operating Profit 24.51 15.61 13.79 9.43 22.36 26.93 22.20 10.18 25.78 15.71 2.21 17.76 4.94
OPM % 30.19% 19.32% 20.75% 14.61% 23.68% 28.84% 24.67% 10.23% 23.51% 15.73% 2.38% 18.47% 5.38%
2.91 5.20 3.48 2.64 1.28 1.65 0.69 4.63 1.82 2.27 1.16 2.88 3.84
Interest 4.93 4.87 5.35 3.99 3.58 5.45 3.93 5.02 4.14 4.42 4.10 4.43 4.47
Depreciation 3.50 3.74 3.81 3.96 4.12 4.78 5.00 6.41 5.95 6.44 6.68 6.49 6.67
Profit before tax 18.99 12.20 8.11 4.12 15.94 18.35 13.96 3.38 17.51 7.12 -7.41 9.72 -2.36
Tax % 26.01% -167.79% -19.11% 24.03% 14.68% 19.78% 29.66% -29.88% 34.04% 41.85% -12.69% 20.58% -8.47%
Net Profit 14.06 32.68 9.66 3.13 13.60 14.71 9.83 4.39 11.54 4.14 -8.34 7.72 -2.56
EPS in Rs 4.74 11.88 3.28 1.07 4.62 5.00 3.33 2.51 3.84 1.53 -2.73 2.61 -0.78
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
76 119 117 139 142 155 164 302 403 292 376 397 381
57 88 94 113 126 134 152 209 248 225 293 335 340
Operating Profit 19 31 23 26 16 21 12 93 156 66 83 62 41
OPM % 25% 26% 20% 19% 11% 13% 7% 31% 39% 23% 22% 16% 11%
23 14 2 3 0 1 3 9 6 12 8 8 10
Interest 1 4 5 5 4 6 10 14 21 20 19 18 17
Depreciation 4 8 9 10 9 8 10 12 12 15 20 26 26
Profit before tax 36 33 10 14 3 7 -6 76 129 43 52 27 7
Tax % 23% 19% 36% 24% 67% 61% -49% 28% 8% -37% 18% 44%
Net Profit 27 25 4 10 1 2 -9 46 117 60 43 15 1
EPS in Rs 9.18 8.07 1.51 2.86 0.17 -0.41 -4.14 12.21 42.71 20.23 15.46 5.25 0.63
Dividend Payout % 23% 31% 124% 29% 249% -51% -5% 2% 1% 24% 16% 23%
Compounded Sales Growth
10 Years: 13%
5 Years: 19%
3 Years: -1%
TTM: -3%
Compounded Profit Growth
10 Years: 0%
5 Years: 30%
3 Years: -50%
TTM: -96%
Stock Price CAGR
10 Years: 14%
5 Years: 30%
3 Years: -12%
1 Year: -23%
Return on Equity
10 Years: 14%
5 Years: 21%
3 Years: 12%
Last Year: 4%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
2 2 2 2 2 2 2 2 5 14 14 14
Reserves 113 127 125 130 129 128 142 122 246 295 346 358
20 37 43 65 71 89 87 173 209 224 232 239
35 50 55 61 60 70 75 87 92 80 94 96
Total Liabilities 171 216 226 259 262 288 307 385 551 614 687 707
46 73 94 87 85 168 172 177 178 200 263 299
CWIP 14 13 15 36 65 6 5 4 22 71 57 35
Investments 41 18 11 17 18 15 18 10 8 0 0 0
70 113 105 118 94 99 112 193 344 342 367 373
Total Assets 171 216 226 259 262 288 307 385 551 614 687 707

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
-1 39 23 14 15 4 2 59 90 34 63 43
-7 -50 -20 -25 -18 -13 7 -101 -97 -44 -41 -26
16 7 -8 13 1 10 -12 89 12 -47 -1 -22
Net Cash Flow 8 -4 -4 2 -2 1 -4 47 6 -57 21 -4

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 81 72 79 106 91 101 99 83 59 87 66 80
Inventory Days 211 210 225 149 125 160 208 234 347 594 441 380
Days Payable 164 155 134 120 95 113 147 183 169 260 169 154
Cash Conversion Cycle 129 127 171 136 122 148 160 134 237 421 338 306
Working Capital Days 99 78 72 73 4 20 115 90 97 202 171 180
ROCE % 19% 18% 9% 10% 4% 6% 2% 34% 41% 12% 13% 7%

Shareholding Pattern

Numbers in percentages

Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022
63.15 59.44 59.44 59.44 59.44 59.44 59.44 59.44 59.44 59.58 59.58 59.58
0.56 0.52 0.52 0.41 0.17 0.25 0.13 0.03 0.01 0.01 0.01 0.01
0.00 0.00 0.00 0.00 0.00 0.24 0.24 0.00 0.00 0.05 0.05 0.05
36.30 38.06 38.06 38.17 38.40 38.09 38.21 38.55 38.57 38.37 38.37 38.37
0.00 1.98 1.98 1.98 1.98 1.98 1.98 1.98 1.98 1.98 1.98 1.98

Documents

Concalls